$TCBP The acceptance of TC BioPharm’s amendment by the MHRA for the ACHIEVE UK trial can be seen as a bullish signal for several reasons:

1. Enhanced Trial Flexibility: The ability to increase the dose level for TCB008 and shift to an outpatient procedure may improve the trial’s efficiency and patient experience. This flexibility could potentially lead to better trial outcomes and patient adherence.
2. Operational Efficiency: Reducing the need for overnight hospital stays for patients after dosing not only improves the quality of life for participants but also eases the burden on clinical sites. This operational efficiency can accelerate the trial’s progress.
3. Positive Regulatory Feedback: Gaining regulatory acceptance for amendments suggests a positive interaction between TC BioPharm and regulatory bodies, indicating that the company is responsive and adaptable to both regulatory requirements and clinical insights.
4. Potential Impact on FDA Trial: The amendments align with the dosing levels of the Investigational New Drug (IND) application for the second cohort, which might streamline the process for the FDA trial. This proactive approach to aligning international trial standards may facilitate smoother regulatory negotiations and trial implementations in multiple jurisdictions.
5. Innovative Treatment Potential: The focus on TCB008 and its application in treating Acute Myeloid Leukemia (AML) underscores TC BioPharm’s commitment to developing innovative cancer treatments. Success in these trials could position the company as a leader in gamma-delta T cell therapies, potentially opening up significant market opportunities.

Larry did said Zomedica will be releasing ZM-017, ZM-020, ZM-022 in the summer of 2022 in the QA. He also said by 2023 there will be 20 available assays for Truforma and there’s currently over 400 placements on Truforma, Zomedica is currently working with 3 franchised Vet Hospitals with a extended network of 3000 offices nationwide. at 75% margin and 100M in annual revenue from PulseVet alone. Thanks CEO Larry

Lol Reddit didn’t bring in 100/200m volume .. I only said that because after your post the other day it jumped 40%. Darkpool, it’s pretty obvious you’re a short seller.

Be honest are you a short seller?.. I see your bearish stand in a lot of other boards.

He spoke.. BUY SIGNAL!!! Imoo

H.C. Wainwright Bioconnect Conference!
Basically it’s a very important Conference for the company to its investors and future investors not RETAIL INVESTORS. This is a very important Conference for Zomedica, which will give us an idea what’s our next steps, where we heading towards, what’s the game plan for 2022. Stock price will probably get addressed because this is an Investor’s Conference, perhaps a buyback since it been on the table for more then a year already. It’s been approved by shareholders and Zomedica so let’s see what happens. ZM-020 Patent granted for 20 year on Aug 31, 2021.. as stated 20 years so expect them to push the product out as soon as possible.

https://stocksera.pythonanywhere.com/ticker/failure_to_deliver/?quote=Iwm

The factual fact the market like Biden more! He’s more predictable actually! Old man goes with the flow.. tries to get his agenda done but clearly gets the foot.

He hold over a million of shares .. and he paid over 120k not under 100k.. what’s really remarkable that your so bearish but your keeping tabs. Keep showing real interests here!

Buying opportunities .. thanks for the wishes.. cut the FUD tho

Keep lurking with full pipeline Zomedica should be valued at 40 billion

Keywords PIPELINE ZM-017 / ZM-020 on the way

Bro he is fully retired.. he came in as a interm ceo and did an amazing job we are sitting on 200m in cash lol

Insider buying board member buys 250k shares at 45 cents he’s averaging up I think you should be to.. it was an option exercise it was cash purchase for over 100k

A lot of patent news on ZM-017/ZM-020
Over 40 PDF files filed yesterday and today! Reason behind insider purchasing 250k shares

Let see how that work out for yall.. Zomedica can't R/S .. they can buy the float back at 30 cents, their cash value for share price is at 30 cents.. you guys are smoking crack.. keep entertaining me

Stop feeding into the narrative guys and make your own!
Key Points
•Zomedica Corp current quarter revenue growth YoY of 123.40% ranked 438 out of 5660 companies
•Weekly/2-4HR Golden Cross.. citadel closed its position here a day before the RICO was filed.
•The R&D expenses reached $0.3M, implying a ~89% decline with the completion of TRUFORMA development. However, SG&A expenses soared ~165% YoY to $6.1M, driven by a $1.5M share-based compensation expense during the period.
•09/2020 144 units placed is more then 2x Last Quarter
•Earning don’t mean shit until they do
•Paperhands show fear and feed down the social sentiment
•Bots and Algo see this and start putting pressure in this group, Stocktwits, Twitter, in all social media platforms.
•The reasons Zomedica is going to be uptrending and has been for past two month $IWM $IWO, we being pushed and the tree will be shaking on multiple occasions like last night. Micro/Small cap in general is going higher going into 2022.
•To sell afterhours you need a buyer so stop the fear, This is a accumulation tactic even a cover attempt.
•The market is in rotation currently and a lot of hedgies are gonna get fucked with their FTD (Fail to Deliver) liquidations are happening and more to come.
•Citadel Closed its full position in @Zomedica on 08/16
•Citadel was charged in RICO case for racketeering on 08/17
•Zomedica is targeting VetCor Banfield Pet Hospital VCA Animal Hospitals
•Share Buy backs are trending current shorts hold 120m in shares I expect Zomedica to buy 100M in shares for under 60M at 50 cent support level which Market Makers made clear to short seller and Zomedica board team when it hit 44 cents and shot to 80 cents.. I found support at 50 cents for the third/fourth time which is a real triple bottom
•ZM-017 Patent is in Final Stages 10/21
•ZM-020 mentioned in Q3 10-k last night
•Larry Heaton used a keyword in his report saying Pulsevet ???? Housecalls Veterinary Centre PulseVet was the “FIRST” acquisition by Zomedica.
•2022 Global Sales Expansion
•200M in Cash Reserves [War Chest]
•50 cents been a key support since 2017 [IPO], should say a lot with current share buy back trend, R/S impossible, moving the company is impossible to Delaware we should see 50/60M dollar buy back by Zomedica because they won’t have this chance again and not like last time they actually have the extra funds to do it and acquire another company with approximately 5 years of funding still left in their War Chest for expenses, r&d, employees
•Cash Flow positive by 2023
•Our true valuation in 2023 should be around 40 Billion with full diagnostic pipeline with current float should put your Price Target on Zomedica in 2023 at $40 a share
•Valuations don’t matter until they do, earnings don’t matter until they do, Citadel short laddered the stock down with a bunch of other “MEME” stocks.. they all run the same Algo as I said in April of 2020. Don’t let the FUD scare you!
•2020 4400% gains from 6 cents to $2.80, if we get those same numbers it’s $20 a share.. $5/6 is a healthy target!
•Zomedica isn’t only going to compete but it will complete the veterinary sector.
•130k Followers on Stocktwits, 380k on Webull a lot of eye on Zomedica.
•Citadel has ownership in Facebook, Stocktwits, Twitter they have eyes and bots everywhere and their one of many short sellers that have bots on social platforms debunking Zomedica. They pay stock media outlets to release articles that benefit them because it also benefits their investors which is JP, Vanguard, BlackRock as they take advantage by averaging down on their Long Term positions as seen after April very heavy institutional sentiment going into Q2 & Q3.


Follow me on Discord at Discord.gg/banlvl3
Learn to Trade & partnered alerts

Follow me on Twitter for most update data on Zomedica and my trades/positions @EYALCap

Of course anytime man

No News and We Rise I knew this 6 months ago and learned the strong support is truly 49/50 cents since 2017 in August.

Leave those emotions in the bedroom .. Stocks & Emotions don’t correlate

Truly hate that website man.. their taking kickbacks degrading companies in the small cap sector it’s truly disgusting.. small business is our back bone in this country if theirs no such thing as middle class wtf would their really be think of it that way. It’s sad shorts sucked the life out of the small cap sector and scared everyone away and divided our community to hate a stock they themselves moved not us. Retailers will never move a stock.. we are trading and investing in controlled environment.. if your trading you want to be out before the leader dumps.. if your investing you take advantage stock up while the price is low and wait for the cycle phases to finish.

By the wave cycle on the cart I seen TAs and Webull support and resistance chart show $6 being the ceiling so I’m saying $5 and then another cycle depending on Russell which is the small cap ETF. If we get to $3 or close to it like anything $2.25.. you will $5 by February March timeline

Good old Russell.. I told you guys once it breaks ATH .. Zom will get its party! And the facts are $IWM ATH, and the party is beginning again.. don’t be late folks

Picking you up soon ??

Good for paperhands.. I can hold 600k+ shares at ease .. you lost several thousand you sound like your crying in your beer in your bear outfit right now.. fun fact it ain’t Halloween no more.. I lost $135,000 before the run up in February did I pull no fucking way.. I know where $ZOM is going and it’s ATH.. please restrain yourself if you don’t have your fact straight or just salty in general no time for that here .. there money to be made everywhere

What’s everyone’s Cost Average?

Let’s be nice ?? .. not everyone understand buy the dip not chips

New All Time Incoming!

Questions for the Investor Relations Department call 1.734.369.2555 Ext. 113

I’ma round you off and say $1 is ST here

markdvm70 (the vet that shared the First Truforma Run! video) is correct in his responses, the numbers below do not lie:

Cost Savings:------------------------------------------

His office has 6.5 DVM's (Doctor of Vet Medicine) and they each run roughly 15 tests per week (T4/FT4/Cortisol tests). Therefore, his office runs a total of 97.5 test a week. (for these calculations, lets round this number down to 90).

His office saves roughly $25 for each test ($70-$45=$25).

Therefore, his office saves $2,250 a week with running tests with Truforma (97.5 tests x $25) and $117,000 a year. THIS IS SIGNIFICANT and could result in a very quick ROI for the vet offices.

Time Savings:------------------------------------------

His office currently waits 2 days for cortisol test results, 48 hours.

His office estimated it takes roughly 2-4 minutes to set up and 15-20 minutes to run a test. 24 minutes max for a test is a savings of roughly 47.5 hours, 99.2% time savings.

90 tests a week (2,400 minutes (5x8x60)) means a test will be ran every 26 minutes with results immediately shown after the test is ran. This means the Truforma will rarely sit idle, therefore, a potential need for additional machines.

I got my response from IR and loaded the boat.. best decision I made!

So you bought the top and crying that you sold at a loss.. nothing more to see here! Keep trading nothing wrong with that .. just catch the train next time before it start moving not when it’s flying lol

$IWM Running will cause us to leg up whenever iwm is lagging right under ATH.. IWM is Running Hotter then other indicas

Shorts starting to Cover!

Your correct, I’m sure the company doesn’t want a media outlet playing red light green light with their Stock.

U mean short seller pay for those articles smh

InvestorPlace with the Upgraded PT “The $1 level should be viewed as an important objective for the remainder of the year. If ZOM stock clears that hurdle with heavy trading volume, then $1.45 and $1.70 will be reasonable targets.” Make them Chase

InvestorPlace “Reasonable to say that Zomedica will continue to be in good hands. As an inventor on several U.S. patents, Heaton brings more than 35 years of executive leadership and operations experience from the medical device and biotechnology industries.

Throughout his lengthy career so far, Heaton has focused extensively on commercialization and business development in both large-cap and early-stage medical-device companies.” Green Light!

Seen the article like is I said their playing red light green light with the stock but they never had an article this bullish on Zomedica .. they basically called my next ST consolidation area before the new year.